In 2025, the deductible cannot exceed $590. Januvia (sitagliptin) is a prescription-only medication for type 2 diabetes. It can work alongside diet and exercise to help lower blood sugar (glucose ...

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug ...

The negotiations lowered the price Medicare will pay for Merck's Januvia, Novo's Fiasp and AstraZeneca's Farxiga by a ...

Meanwhile Steglujan (ertugliflozin+sitagliptin), a fixed dose combination combining the SGLT2 with Merck’s Januvia, is approved in type 2 disease when patients who need both drugs. Ertugliflozin ...